Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
29.55
+0.11 (0.37%)
Jul 28, 2026, 1:07 PM EDT - Market open
Damora Therapeutics Employees
Damora Therapeutics had 7 employees as of December 31, 2025. The number of employees increased by 2 or 40.00% compared to the previous year.
Employees
7
Change (1Y)
2
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$33,584,143
Market Cap
1.82B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7 | 2 | 40.00% |
| Dec 31, 2024 | 5 | -8 | -61.54% |
| Dec 31, 2023 | 13 | -32 | -71.11% |
| Dec 31, 2022 | 45 | 5 | 12.50% |
| Dec 31, 2021 | 40 | 12 | 42.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Immunocore Holdings | 524 |
| Lakefront Biotherapeutics NV | 452 |
| Maravai LifeSciences Holdings | 416 |
| Syndax Pharmaceuticals | 298 |
| Kardigan | 241 |
| Stoke Therapeutics | 170 |
| Bicara Therapeutics | 103 |
DMRA News
- 1 day ago - Damora Therapeutics initiated with a Buy at Jefferies - TheFly
- 11 days ago - Damora Therapeutics completes redomestication to the Cayman Islands - TheFly
- 11 days ago - Damora Announces Redomestication from Delaware to Cayman Islands - GlobeNewsWire
- 26 days ago - Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Damora Therapeutics Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Damora Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 2 months ago - Wedbush bullish on Damora Therapeutics, initiates with an Outperform - TheFly
- 2 months ago - Damora Therapeutics initiated with an Outperform at Wedbush - TheFly